Alder BioPharmaceuticals, Inc.

Alder BioPharmaceuticals, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Alder BioPharmaceuticals, Inc. is not very popular among insiders. Alder BioPharmaceuticals, Inc. is a mediocre stock to choose.
Log in to see more information.
Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers, devel...

News